Kanbayashi, Yuko http://orcid.org/0000-0002-4680-5133
Sakaguchi, Koichi
Ishikawa, Takeshi
Tabuchi, Yusuke
Takagi, Ryo
Yokota, Isao
Katoh, Norito
Takayama, Koichi
Taguchi, Tetsuya
Article History
Received: 21 March 2022
Accepted: 17 May 2022
First Online: 19 July 2022
Declarations
:
: Isao Yokota has received a speaker’s fee from Chugai Pharmaceutical Co., Ltd. Norito Katoh has been a speaker and investigator for Taiho Pharmaceutical Co., Ltd. Tetsuya Taguchi received a speaker’s fee and research funds from Taiho Pharmaceutical and Chugai Pharmaceutical Co., Ltd. All other authors declare that they have no conflicts of interest concerning this work.
: Written, consent for publication was obtained from all patients prior to their enrollment.
: This trial was approved by the Medical Ethics Review Committee of Kyoto Prefectural University of Medicine, in accordance with the tenets of the Declaration of Helsinki (approval no. ERB-C-906-1).
: Written, informed consent was obtained from all patients prior to their enrollment.